Magaly Colon
Acute Care · Stockbridge, GANPI 1235615238
Payments from drug & device makers
Across 59 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$196
- AstraZeneca$192
- Bayer$133
- Lilly USA, LLC$128
- Convatec Inc.$125
- Novo Nordisk$115
- plus $363 from 10 others
What the payments were for
- Food & beverage$1,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $196 |
| AstraZeneca | 9 | $192 |
| Bayer | 7 | $133 |
| Lilly USA, LLC | 6 | $128 |
| Convatec Inc. | 1 | $125 |
| Novo Nordisk | 5 | $115 |
| GSK | 4 | $85 |
| Exact Sciences | 5 | $81 |
| Astellas Pharma US Inc | 4 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Boston Scientific | 1 | $23 |
| Pfizer | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Phadia US Inc. | 1 | $14 |
| Cequr Corporation | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$125
How this compares
$1,252 in reported general payments places this provider in the 75th percentile of 679 acute care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $739 |
| Gabapentin | 18 | $452 |
| Atorvastatin Calcium | 46 | $320 |
| Omeprazole | 18 | $191 |
| Levothyroxine Sodium | 16 | $186 |
| Montelukast Sodium | 14 | $170 |
| Rosuvastatin Calcium | 13 | $154 |
| Amlodipine Besylate | 34 | $151 |
| Metformin Hcl | 31 | $141 |
| Doxycycline Hyclate | 14 | $138 |
| Metoprolol Succinate | 14 | $126 |
| Methylprednisolone | 26 | $124 |
| Losartan Potassium | 15 | $96 |
| Tamsulosin Hcl | 12 | $80 |
| Lisinopril | 18 | $63 |
Paid to pharmacies, not to this prescriber.
Other acute care in Stockbridge
- Denise ClaridyStockbridge$7K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
- Ayeshia PowellAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.